Companies
-
Sandoz tops GPTW rankings for 2026
- Fri Oct 2
Great Place to Work reveals the Top 10 Biotech and Pharma Companies of 2026, Sandoz beating out four innovative companies to top the 2026 list.
Read more -
Boehringer named ‘best in class’ by ANZ patients
- Wed Sep 30
For the second year in a row, Boehringer Ingelheim has been named by patient organisations as having the best reputation in ANZ. See who else ranked, and who’s improved.
Read more -
Guild, PSA unite against ‘Big Pharma’ dispensing model
- Mon Sep 28
Describing Lilly’s new dispensing tender as a ‘Big Pharma-driven medicine supply model’, pharmacy owners and pharmacists are fighting back.
Read more -
Female leaders step into new roles
- Mon Sep 28
Surge of senior promotions and appointments favours female leaders across Australian pharma as an Aussie star continues her rise at J&J EMEA.
Read more -
Dengue travel vax gets ATAGI approval
- Mon Sep 28
Takeda’s dengue Qdenga offers travellers a new layer of protection against a disease that shadows popular holiday destinations.
Read more -
Boehringer is moving, but will stay in Pill Hill
- Fri Sep 25
Boehringer Ingelheim is defying the trend away from Pill Hill, announcing it is moving – but will stay in Macquarie Park.
Read more -
Lilly set to disrupt medicines supply chain
- Wed Sep 23
LillyDirect may well be to community pharmacy what Uber was to taxis; taxis are still there, but if given a choice, most people choose Uber.
Read more -
AstraZeneca to keep Zoladex on PBS longer
- Wed Sep 23
AstraZeneca will keep Zoladex on the PBS for another six months but after that, the product will be withdrawn from Australia.
Read more